Literature DB >> 15175902

Changes in liver enzymes after surgery in anti-hepatitis C virus-positive patients.

Saburo Murakami1, Katsuhiko Okubo, Yoshitaka Tsuji, Hideto Sakata, Takehiro Takahashi, Masataka Kikuchi, Renzo Hirayama.   

Abstract

The aim of this study was to assess the influence of surgical intervention on changes in liver enzymes in patients with antibodies to hepatitis C virus (HCV). Of 623 patients who underwent laparotomy in our department during the 2 years between January 2000 and December 2001, a group of 39 (6.3%) who were positive for the HCV antibody were enrolled in this study. Serum levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), lactate dehydrogenase (LDH), and cholinesterase (ChE) were the standard liver tests performed. The antibody to HCV was measured in serum using an ELISA kit that can detect antibodies against the combined epitopes. The postoperative elevated values of AST and ALP in the anti-HCV-positive group were significantly higher than those in the anti-HCV-negative group ( p < 0.05). The postoperative decreased values of ChE in the anti-HCV-positive group were significantly greater than those in the anti-HCV-negative group ( p < 0.02). The postoperatively decreased ratios of ChE in the anti-HCV positive group were significantly greater than those in the anti-HCV negative group ( p < 0.0001). Using multivariate logistic regression modeling, testing positive for the antibody to HCV was independently and significantly associated with abnormal levels of ALT and ALP ( p = 0.035 and 0.018, respectively). Monitoring liver enzymes such as ChE, ALT, and ALP might be effective for evaluating liver function after surgery in anti-HCV-positive patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175902     DOI: 10.1007/s00268-004-7377-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  22 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Disturbances in hepatic blood flow during anesthesia and surgery.

Authors:  S I Gelman
Journal:  Arch Surg       Date:  1976-08

3.  Chronic active hepatitis: possible adverse effect of exploratory laparotomy.

Authors:  M D Hargrove
Journal:  Surgery       Date:  1970-11       Impact factor: 3.982

4.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

5.  Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Gibo; K Yoshizawa; Y Nakano; S Furuta; Y Akahane; K Nishioka; R H Purcell
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

Review 6.  Surgery in the patient with liver disease.

Authors:  T Patel
Journal:  Mayo Clin Proc       Date:  1999-06       Impact factor: 7.616

7.  Risk of blood contamination and injury to operating room personnel.

Authors:  E J Quebbeman; G L Telford; S Hubbard; K Wadsworth; B Hardman; H Goodman; M S Gottlieb
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

8.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

9.  Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis.

Authors:  R N Garrison; H M Cryer; D A Howard; H C Polk
Journal:  Ann Surg       Date:  1984-06       Impact factor: 12.969

10.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

View more
  6 in total

1.  Study of hepatotoxicity and oxidative stress in male Swiss-Webster mice exposed to functionalized multi-walled carbon nanotubes.

Authors:  Anita K Patlolla; Ashley Berry; Paul B Tchounwou
Journal:  Mol Cell Biochem       Date:  2011-07-03       Impact factor: 3.396

2.  Biochemical and Histopathological Evaluation of Graphene Oxide in Sprague-Dawley Rats.

Authors:  A K Patlolla; J Rondalph; P B Tchounwou
Journal:  Austin J Environ Toxicol       Date:  2017-12-07

3.  Association of laboratory parameters with viral factors in patients with hepatitis C.

Authors:  Bushra Ijaz; Waqar Ahmad; Fouzia T Javed; Sana Gull; Muhammad T Sarwar; Humera Kausar; Sultan Asad; Shah Jahan; Saba Khaliq; Imran Shahid; Aleena Sumrin; Sajida Hassan
Journal:  Virol J       Date:  2011-07-21       Impact factor: 4.099

4.  HCV genotype-specific correlation with serum markers: higher predictability for genotype 4a.

Authors:  Waqar Ahmad; Bushra Ijaz; Fouzia T Javed; Humera Kausar; Muhammad T Sarwar; Sana Gull; Sultan Asad; Imran Shahid; Sajida Hassan
Journal:  Virol J       Date:  2011-06-10       Impact factor: 4.099

5.  Analytical assessment of interleukin - 23 and -27 cytokines in healthy people and patients with hepatitis C virus infection (genotypes 1 and 3a).

Authors:  Asghar Ashrafi Hafez; Abbas Ahmadi Vasmehjani; Rasoul Baharlou; Seyed Dawood Mousavi Nasab; Mohammad Hasan Davami; Ahmad Najafi; Negar Joharinia; Hasan Rezanezhad; Nayeb Ali Ahmadi; Masoumeh Imanzad
Journal:  Hepat Mon       Date:  2014-09-27       Impact factor: 0.660

6.  Altered of apoptotic markers of both extrinsic and intrinsic pathways induced by hepatitis C virus infection in peripheral blood mononuclear cells.

Authors:  Guilherme Albertoni; Carine Prisco Arnoni; Flávia Roche Moreira Latini; Sheila Siqueira Andrade; Patrícia Regina Barboza Araújo; Flaviane Kesia Rodrigues; Patrícia Bortman Rozenchan; Maria Cássia Mendes-Correa; Olavo Henrique Munhoz Leite; Nestor Schor; Manoel João Castelo Batista Girão; José Augusto Barreto
Journal:  Virol J       Date:  2012-12-20       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.